BCG Vaccine Complications and Immunodeficiency in Children
Author Information
Author(s): Fazlollahi Mohammad Reza, Goudarzi Ali, Nourizadeh Maryam, Alizadeh Zahra, Tajik Shaghayegh, Badalzadeh Mohsen, Sarafzadeh Shokouh Azam, Mahlooji Rad Maryam, Adab Zeinab, Moradi Leila, Razaghian Anahita, Sabetkish Nastaran, Pourpak Zahra, Moin Mostafa
Primary Institution: Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran
Hypothesis
Can early complications from the BCG vaccine indicate underlying inborn errors of immunity in neonates?
Conclusion
Early complications from the BCG vaccine may signal an underlying immunodeficiency, suggesting the need for immunological screening before vaccination.
Supporting Evidence
- 197 patients with BCG vaccine complications were identified from a total of 3,275 suspected cases.
- 64.5% of the patients were male, and symptoms began at or before 3 months of age in 64.8% of cases.
- 79.2% of patients reported parental consanguinity, indicating a potential genetic link to immunodeficiency.
Takeaway
If a baby has problems after getting the BCG vaccine, it might mean they have a hidden health issue with their immune system.
Methodology
This cross-sectional study analyzed 3,275 children suspected of immunodeficiency, identifying 197 with BCG vaccine complications and conducting immunological tests.
Potential Biases
Potential bias due to the study being conducted at a single institution.
Limitations
The study is institutional-based and may not reflect the true prevalence of BCG complications in the general population.
Participant Demographics
64.5% male, 79.2% reported parental consanguinity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website